Ignite Creation Date:
2024-05-06 @ 2:50 AM
Last Modification Date:
2024-10-26 @ 11:24 AM
Study NCT ID:
NCT02143635
Status:
COMPLETED
Last Update Posted:
2021-05-21
First Post:
2014-05-19
Brief Title:
Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid and Hematological TP53wt Tumors |
Keywords:
| Name | View |
|---|---|
| HDM201TP53wt p53 MDM2 HDM2 advanced tumors BLRM Bayesian logistic regression model | View |